Goodness Growth Holdings Appoints Josh Rosen to Board of Directors


MINNEAPOLIS, August 13, 2021 / PRNewswire / – Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), a science-driven, physician-led cannabis company and property incubator intellectual, today announced that its Board of Directors has appointed Josh Rosen to its board of directors, again bringing the number of directors to seven.

Josh Rosen is a Managing Partner at Bengal Capital, and a former Managing Director and Chairman of 4Front Ventures. At 4Front, Josh helped lead the transformation from an industry-leading consulting firm into an operations-focused multi-state operator, including with the acquisition of Cannex Capital in 2019. Prior to 4Front, Josh acquired a Private Equity experience managing the investment portfolio of a large family office and has worked extensively in public markets as an equity analyst, primarily at global investment bank Credit Suisse.

“We are delighted to welcome Josh Rosen to our Board of Directors and I look forward to his contribution as a proven leader and strategic advisor to the cannabis industry as we assess critical decisions for our business, ”said the President and CEO, Kyle kingsley, MD. “We are on the cusp of transformative growth as our markets shift from medical to adult use, and Josh immediately infuses our team with valuable cannabis experience during a time when we assess many strategic opportunities. in real time. In addition to its operational expertise. , his background and relationships in the capital markets, as well as his knowledge of executing strategic transactions will be of tremendous benefit to our team. “

“Josh’s reputation and success in the cannabis industry was very appealing to us and we are pleased to invite him to join our board of directors. Our early interactions with Josh gave us confidence that he will add value to the organization, and we look forward to his support on corporate governance matters with interests clearly aligned with our shareholders, ”said Chelsea Grayson, independent director of Goodness Growth Holdings.

Josh Rosen commented, “Bengal Capital has been investing in the cannabis industry in the United States since its 2013 seed investment in Green Thumb Industries. Today, Goodness Growth represents one of Bengal Capital’s most compelling investment ideas, and we believe our goal is to work closely with management teams as committed shareholders can help maximize value in this rapidly changing sector. I have always been impressed with the portfolio of assets that Kyle’s team has assembled and look forward to supporting the management team and the board of directors of the company throughout the next phase of growth. of the society. “

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a doctor-led, science-driven holding company with a mission to bring the power of plants to the world. The Company’s business consists primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures cannabis products from exclusive brand in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of green products® and other third-party retail outlets and dispensaries. Its team of more than 500 employees is focused on developing differentiated products, promoting scientific innovation of herbal medicines and developing meaningful intellectual property. Today, the company is licensed to cultivate, process and / or distribute cannabis in eight markets and operates 18 dispensaries across United States. For more information on Goodness Growth Holdings, please visit

Contact details

Investor surveys:

Media inquiries:

Sam gibbon

Albe zakes

Vice-President, Investor Relations

Vice-President, Corporate Communications

[email protected]

[email protected]

(612) 314-8995

(267) 221-4800

SOURCE Goodness Growth Holdings, Inc.

Source link


Comments are closed.